The Pharmaceutical Industry in the UK

66,000 jobs in 2020 — People employed by the pharmaceutical sector in 2021 [1]

Life sciences apprenticeships started in 20/21 [4]

Total Voluntary Scheme payments to the NHS after 5 years [5]

Phase III UK industry clinical trials started in 2021 [6]

References:

1. Bioscience and health technology sector statistics 2021
https://www.gov.uk/government/statistics/bioscience-and-health-technology-sector-statistics-2021/bioscience-and-health-technology-sector-statistics-2021#:~:text=Employment%20in%20core%20businesses%20was,in%20the%20core%20biopharmaceutical%20sector

2. Business enterprise research and development, UK: 2021 (see Business enterprise research and development time series, cell BF48)
https://www.ons.gov.uk/economy/governmentpublicsectorandtaxes/researchanddevelopmentexpenditure/bulletins/businessenterpriseresearchanddevelopment/2021

3. Office for National Statistics, Trade in Goods: Country-by-commodity exports, accessed 20 March 2023

4. Life Sciences Competitiveness Indicators 2022.
https://www.gov.uk/government/publications/life-science-sector-data-2022/life-science-competitiveness-indicators-2022#research-environment-1

5. DHSC: 2019 voluntary scheme for branded medicines pricing and access: payment percentage for 2023, accessed 5 April 2023. Estimate based on actual and forecasted payment rates and sales data.
https://www.gov.uk/government/publications/the-2019-voluntary-scheme-for-branded-medicines-pricing-and-access-payment-percentage-for-2023/the-2019-voluntary-scheme-for-branded-medicines-pricing-and-access-payment-percentage-for-2023

6. ABPI: Rescuing Patient Access to Industry Clinical Trials in the UK, October 2022.
https://www.abpi.org.uk/media/news/2022/october/nhs-patients-losing-access-to-innovative-treatments-as-uk-industry-clinical-trials-face-collapse/

Industry data

Close-up of hands typing on a laptop, with a microscope in the background, being reflected on the screen

UK pharmaceutical market

The pharmaceutical industry is an important sector in the UK. The tables below show some key data on the UK expenditure on medicines, as well as UK jobs in the industry and the industry's contribution to the UK economy.

Two scientists discussing are standing in a lab in front of a microscope on the bench.

Global pharmaceutical market

Medicines and vaccines have helped deliver incredible improvements in health. This section look at how the UK compare with global trends in health and pharmaceuticals.

Doctor sat in in their surgery talking with a patient

Clinical trials

Medicines and vaccines have helped deliver incredible improvements in patient health. This section looks at expenditure on R&D in the UK and around the world, clinical trials by phase and by therapy area and research intensity.

Close-up of the face of a scientist close to her microscope

Cancer in the UK - Digital Data Toolkit

Cancer survival in the UK has improved over recent years, with more people living five years or more with the disease than ever before. However, despite this progress, cancer remains one of the UK’s leading causes of death. More can be done to improve cancer outcomes for those affected. By looking at how the UK compares to other European countries, we can begin to consider how this can be achieved.

Three young scientists are working with chemicals inside a chemical fume hood

Industry and academia links survey 2019

Since 2003, the Association of the British Pharmaceutical Industry (ABPI) has gathered information biennially from member companies on their links with academia and the NHS. Links between academia and the NHS can be grouped by areas or by career development path.

Medicine discovery - facts and figures

Medicines bring huge value to NHS patients. The development of new medicines is uncertain, costly, and involves significant rates of failure. The pharmaceutical industry spends $160 billion per year on research and development.